Osteoporosis International

, Volume 6, Supplement 3, pp 11–15

Epidemiology of hip fracture: The MEDOS study

  • G. P. Lyritis
  • the MEDOS Study Group


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cooper C, Campion G, Melton LJ III. Hip fractures in the elderly: a worldwide projection. Osteoporosis Int 1992;2:285–9.Google Scholar
  2. 2.
    Melton LJ III. Hip fractures: a worldwide problem today and tomorrow. Bone 1993;14:S1–8.Google Scholar
  3. 3.
    Cummings SR, Nevitt MC. Epidemiology of hip fractures and falls. In: Kleerekoper M, Krane SM, editors. Clinical disorders of bone and mineral metabolism. New York: Mary Ann Liebert Inc., 1989:231–6.Google Scholar
  4. 4.
    Agnusdei D, Camporeale A, Gerardi D, Rossi S, Bocchi L, Gennari C. Trends in the incidence of hip fracture in Siena, Italy, from 1980 to 1991. Bone 1993;4:S31–4.Google Scholar
  5. 5.
    Poyser A. Osteoporotic fracture. MEDOS. Sandorama 1993, Special 1, Bone Disease and Fracture. 23–28.Google Scholar
  6. 6.
    Dequeker J, Tobing L, Rutten V, Guusens P, and the MEDOS Study Group. Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire. Clinical Rheumatol 1991;10:49–53.Google Scholar
  7. 7.
    Dequeker J, Ranstam J, Valsson J, Sigurgeirsson B, Allander E, and the MEDOS Study Group. The Mediterranean Osteoporosis (MEDOS) Study Questionnaire. Clin Rheumatol 1991;10:54–72.Google Scholar
  8. 8.
    Allander E, Lindahl BIB, and the MEDOS Group. The Mediter-rannean Osteoporosis Study (MEDOS): theoretical and practical issues of a major international project on hip fracture epidemiology. Bone 1993;14:S37–43.Google Scholar
  9. 9.
    Johnell O, Guilberg B, Allander E, Kanis JA, and the MEDOS Study Group. The apparent incidence of hip fracture in Europe: a study of national register sources. Osteoporosis Int 1992;2:298–302.Google Scholar
  10. 10.
    Elffors I, Allander E, Kanis JA, Guilberg B, Johnell O, Dequeker J, et al. The variable incidence of hip fracture in Southern Europe: the MEDOS Study. Osteoporosis Int 1994;4:253–63.Google Scholar
  11. 11.
    Miravet L, Chaumet-Riffaud, Ranstam J. Residential care and risk of proximal femur fracture. Bone 1993;14:S73–6.Google Scholar
  12. 12.
    Johnell O, Guilberg B, Kanis JA, Allander E, Elffors L, Dequeker J, et al. Risk factors for hip fracture in European women. J Bone Miner Res 1995;10:1802–15.Google Scholar
  13. 13.
    Dequeker J, Johnell O, and the MEDOS Study Group. Osteoarthritis protects against femoral neck fractures: the MEDOS Study experience. Bone 1993;14:S51–6.Google Scholar
  14. 14.
    Kanis JA, Johnell O, Guilberg B, Allander E, Dilsen G, Gennari C, et al. Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ 1992;305:1124–8.Google Scholar
  15. 15.
    Mazzuoli GF, Gennari C, Passeri M, Acca M, Camporeale A, Pioli G. Hip fracture in Italy: epidemiology and preventive efficacy of bone-active drugs. Bone 1993;14:S81–4.Google Scholar
  16. 16.
    Johnell O, Stenbeck M, Rosen M, Kanis JA. Therapeutic strategies in the prevention of hip fracture with drugs affecting bone metabolism. Bone 1993;14:S85–7.Google Scholar
  17. 17.
    Lyritis GP, Johnell O, Orthopaedic management of hip fracture. Bone 1993;14:S11–7.Google Scholar
  18. 18.
    Lyritis GP. Epidemiology and socio-economic cost of osteoporotic fractures in Greece. Calcif Tissue Int 1992;51:93–4.Google Scholar
  19. 19.
    Rapadao A, Gavilanes, EL, Castro N, Vallejo JC. Consequences of hip fracture. 1992 MEDOS Meeting, Lisbon, Portugal. Abstract book, p 21.Google Scholar

Copyright information

© European Foundation for Osteoporosis 1996

Authors and Affiliations

  • G. P. Lyritis
    • 1
  • the MEDOS Study Group
  1. 1.Laboratory for Research on the Musculoskeletal SystemUniversity of Athens, KAT HospitalKifissiaGreece

Personalised recommendations